Patents by Inventor Stacy Remiszewski

Stacy Remiszewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109883
    Abstract: Novel thiazole- and/or isoquinoline-containing compounds are presented that are useful for treating cancers as well as treating and/or preventing viral infections. Methods of treating and/or preventing broad-spectrum viral infections are also presented. These compounds have been shown to inhibit HCMV, influenza virus, and coronavirus replication in cell-based assays.
    Type: Application
    Filed: December 30, 2021
    Publication date: April 4, 2024
    Applicant: Evrys Bio, LLC
    Inventors: STACY REMISZEWSKI, LILLIAN W. CHIANG, FRANK KAYSER, SARAH JOCELYN FINK
  • Publication number: 20230416241
    Abstract: Novel thiazole- and isoquinoline-containing compounds are presented that are useful for treating and/or preventing broad-spectrum viral infections. Methods of treating and/or preventing broad-spectrum viral infections are also presented. These compounds have shown inhibition of HCMV, influenza viruses, Zika virus, BK Virus and RSV replication in cell-based assays.
    Type: Application
    Filed: July 14, 2022
    Publication date: December 28, 2023
    Applicant: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Lillian W. Chiang, Eain Anthony Murphy, Qun Sun, Frank Kayser, Sarah Jocelyn Fink
  • Patent number: 11459321
    Abstract: Novel thiazole- and isoquinoline-containing compounds are presented that are useful for treating and/or preventing broad-spectrum viral infections. Methods of treating and/or preventing broad-spectrum viral infections are also presented. These compounds have shown inhibition of HCMV, influenza viruses, Zika virus, BK Virus and RSV replication in cell-based assays.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: October 4, 2022
    Assignee: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Lillian W. Chiang, Eain Anthony Murphy, Qun Sun, Frank Kayser, Sarah Jocelyn Fink
  • Patent number: 11358961
    Abstract: Novel compounds useful for treating and/or preventing HCMV infections are provided.
    Type: Grant
    Filed: December 22, 2019
    Date of Patent: June 14, 2022
    Assignee: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillian Chiang
  • Publication number: 20220135556
    Abstract: Novel compounds useful for treating and/or preventing HCMV infections are provided.
    Type: Application
    Filed: January 13, 2022
    Publication date: May 5, 2022
    Applicant: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillian Chiang
  • Publication number: 20210139475
    Abstract: Novel thiazole- and isoquinoline-containing compounds are presented that are useful for treating and/or preventing broad-spectrum viral infections. Methods of treating and/or preventing broad-specturm viral infections are also presented. These compounds have shown inhibition of HCMV, influenza viruses, Zika virus, BK Virus and RSV replication in cell-based assays.
    Type: Application
    Filed: October 17, 2018
    Publication date: May 13, 2021
    Applicant: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Lillian W. Chiang, Eain Anthony Murphy, Qun Sun, Frank Kayser, Sarah Jocelyn Fink
  • Publication number: 20210040049
    Abstract: This document relates to compounds useful as agents for preventing or treating human cytomegalovirus (HCMV) infections.
    Type: Application
    Filed: June 21, 2020
    Publication date: February 11, 2021
    Applicant: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillian Chiang
  • Patent number: 10723708
    Abstract: This document relates to compounds useful as agents for preventing or treating human cytomegalovirus (HCMV) infections.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: July 28, 2020
    Assignee: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillian Chiang
  • Publication number: 20200140429
    Abstract: Novel compounds useful for treating and/or preventing HCMV infections are provided.
    Type: Application
    Filed: December 22, 2019
    Publication date: May 7, 2020
    Applicant: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillian Chiang
  • Patent number: 10556894
    Abstract: Novel compounds useful for treating and/or preventing HCMV infections are provided.
    Type: Grant
    Filed: November 9, 2015
    Date of Patent: February 11, 2020
    Assignee: Evrys Bio, LLC
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillian Chiang
  • Publication number: 20180291016
    Abstract: Novel compounds useful for treating and/or preventing HCMV infections are provided.
    Type: Application
    Filed: November 9, 2015
    Publication date: October 11, 2018
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillan Chiang
  • Patent number: 10053431
    Abstract: Disclosed are compounds of Formula I, or pharmaceutically acceptable salts thereof, wherein W, X, Y, Z, R1, R2, R3, R4 and R5 are as described in this application, and methods of using said compounds in the treatment of cancer.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: August 21, 2018
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Shaoqing Chen, Andrew F. Donnell, Robert Francis Kester, Kang Le, Yan Lou, Christophe Michoud, Stacy Remiszewski, Kenneth C. Rupert, Martin Weisel
  • Publication number: 20180170884
    Abstract: This document relates to compounds useful as agents for preventing or treating human cytomegalovirus (HCMV) infections.
    Type: Application
    Filed: November 9, 2015
    Publication date: June 21, 2018
    Inventors: Stacy Remiszewski, Emre Koyuncu, Qun Sun, Lillian Chiang
  • Patent number: 9611224
    Abstract: Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein W, X, Y, Z, R1, R2, R3 and R4 are described in this application, and methods of using said compounds in the treatment of cancer.
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: April 4, 2017
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Xiaochun Han, Yan Lou, Christophe Michoud, Steven Gregory Mischke, Stacy Remiszewski, Kenneth Carey Rupert
  • Publication number: 20160272596
    Abstract: Disclosed are compounds of Formula I, or pharmaceutically acceptable salts thereof, wherein W, X, Y, Z, R1, R2, R3, R4 and R5 are as described in this application, and methods of using said compounds in the treatment of cancer.
    Type: Application
    Filed: November 14, 2014
    Publication date: September 22, 2016
    Inventors: Shaoqing Chen, Andrew F. Donnell, Robert Francis Kester, Kang Le, Yan Lou, Christophe Michoud, Stacy Remiszewski, Kenneth C. Rupert, Martin Weisel
  • Patent number: 9422331
    Abstract: Disclosed are compounds of Formula I or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3, R4 and R5 are described herein, and methods of using said compounds in the treatment of cancer.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: August 23, 2016
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Andrew Forrest Donnell, Robert Kester, Yan Lou, John Anthony, Stacy Remiszewski
  • Patent number: 9422332
    Abstract: Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, m, n and q are described in this application, and methods of using said compounds in the treatment of cancer.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: August 23, 2016
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Joan Heather Hogg, Kang Le, Yan Lou, Steven Gregory Mischke, Stacy Remiszewski
  • Patent number: 9403768
    Abstract: Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3 and R4 are as described in this application, and methods of using said compounds in the treatment of cancer.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: August 2, 2016
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Joan Heather Hogg, Stacy Remiszewski, Weiya Yun
  • Patent number: 9394263
    Abstract: There are provided compounds of the formula wherein: V, W, X, Y, Z, R1, R2, R3, R4, R5 and R6 are described herein. The compounds are useful for the treatment of proliferative diseases, including cancer.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: July 19, 2016
    Assignee: F. HOFFMANN-LA ROCHE AG
    Inventors: Andrew F. Donnell, Xiaochun Han, Robert Francis Kester, Norman Kong, Kang Le, Yan Lou, Christophe Michoud, John Anthony Moliterni, Stacy Remiszewski, Kenneth Carey Rupert, Weiya Yun
  • Publication number: 20150361059
    Abstract: There are provided compounds of the formula wherein: V, W, X, Y, Z, R1, R2, R3, R4, R5 and R6 are described herein. The compounds are useful for the treatment of proliferative diseases, including cancer.
    Type: Application
    Filed: August 6, 2013
    Publication date: December 17, 2015
    Applicant: Hoffman-La Roche Inc.
    Inventors: Andrew F. Donnell, Xiaochun Han, Robert Francis Kester, Norman Kong, Kang Le, Yan Lou, Christophe Michoud, John Anthony Moliterni, Stacy Remiszewski, Kenneth Carey Rupert, Weiya Yun